Please login to the form below

Not currently logged in
Email:
Password:

Moderna

This page shows the latest Moderna news and features for those working in and with pharma, biotech and healthcare.

Merck’s Keytruda combination receives CHMP recommendation for biliary tract cancer

Merck’s Keytruda combination receives CHMP recommendation for biliary tract cancer

There are also currently more than 1, 600 trials studying the therapy, including one evaluating it in combination with Merck and Moderna’s investigational skin cancer vaccine.

Latest news

More from news
Approximately 98 fully matching, plus 163 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 14 partially matching documents found.

Latest appointments

More from appointments
Approximately 3 fully matching, plus 6 partially matching documents found.

Latest from PMHub

  • The future of nanomedicine regulation The future of nanomedicine regulation

    In their latest blog, Hanover Brussels Alicia Rojo Santos and Pilar Serrano explores why the sector expecting to set off following the success of the Pfizer and Moderna SARS-CoV-2 ... With the emergency use authorisation and success of the Pfizer and

  • Clinical trials and the diversity principle

    The following month, it happened again. Cambridge, Massachusetts-based Moderna said it had slowed enrolment in its phase 3 COVID-19 vaccine trial to ensure they were getting a representative population. ... Moderna effectively sacrificed potential sales,

  • Mistrust in medical research: a patient perspective

    15]. In fact, Moderna slowed down recruitment for its COVID-19 vaccine trial specifically to address a shortfall in recruitment from ethnically diverse populations for an illness that has been shown

  • Is the world ready for a COVID-19 vaccine?

    Since then, other good news has followed, with collaborations, including Moderna and AstraZeneca, publishing similarly positive results. ... Since this initial announcement, other good news in vaccine development has followed, with companies and

  • Hanover Communications Hanover Communications

    In their latest blog, Hanover Brussels Alicia Rojo Santos and Pilar Serrano explores why the sector expecting to set off following the success of the Pfizer and Moderna SARS-CoV-2 ... Since then, other good news has followed, with collaborations,

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
11 London

We live in a hyper-connected world. This has clear benefits for the health of our communities, our businesses and our...

Latest intelligence

New Playbook Alert: Virtual Patient Engagement
...
Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...
The problem with clinical trials (and how virtual insight-gathering can help)
While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....